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Abstract 
Aim: To test whether implants placed with simultaneous guided bone regeneration 
(GBR) differ from implants placed without GBR regarding survival rate, interproximal 
marginal bone level (MBL), and dimensions of buccal bone and mucosa. 
Material & Methods: Twenty-three patients treated 15 years earlier were included. 
Machined implants had been inserted following one of the two procedures: (1) with 
simultaneous GBR, which involved grafting with particulate deproteinized bovine bone 
mineral (DBBM), autogenous bone (AB) or a mixture of the two and defect covering with a 
native collagen membrane (CM), (GBR group) and (2) standard implant placement without 
GBR (control group). One GBR and one control implant in each patient were selected for 
analysis. At 15 years, the dimensions of buccal bone and mucosa were measured with cone 
beam computed tomography. The interproximal MBL was evaluated at 5 and 15 years on 
periapical radiographs. 
Results: The 15-year survival rate amounted to 95.6% for GBR implants and to 
94.1% for control implants. At 15 years, interproximal MBL measured 1.44±0.84 mm for the 
GBR group and 1.69±0.84 mm for the control group. From the 5- to the 15-year examination, 
the loss of interproximal MBL reached 0.23±0.70 mm for the GBR group and 0.28±0.63 mm 
for the control group. At 15 years, buccal MBL measured 1.98±0.98 mm for GBR implants 
and 2.19±1.29 mm for control implants. None of these values reached statistical significant 
differences between the groups. In cases in which GBR involved grafting with DBBM, GBR 
implants achieved approximately 0.3-0.4 mm higher mean values in buccal bone dimensions 
and mucosal level in comparison to control implants. In contrast, when GBR was performed 
by grafting with AB without DBBM, implants rendered less favorable results in buccal bone 
and mucosa dimensions than the control implants. 
Conclusions: Implants placed with simultaneous GBR by using particulate DBBM 
and/or AB in combination with CM did not significantly differ from implants completely placed 
into pristine bone with respect to 15-year implant survival, interproximal bone levels, and 
dimensions of buccal bone and mucosa. The machined-surface implants placed both into 
native bone and sites augmented by GBR exhibited stable interproximal bone levels. 
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Clinical relevance 
Scientific rationale: Even though guided bone regeneration is the most widely used 
method applied to augment bone in localized alveolar defects, there is scarce clinical 
evidence comparing the long-term results of implants placed with guided bone regeneration 
and those placed into pristine bone. 
Principal findings: Implants placed with simultaneous guided bone regeneration by 
using particulate deproteinized bovine bone mineral and/or autogenous bone in combination 
with collagen membrane did not differ from implants completely placed into pristine bone 
with respect to 15-year implant survival, interproximal bone levels, and dimensions of buccal 
bone and mucosa. 
Practical implications: Within the limitation of this study, the presence of peri-
implant defects treated with guided bone regeneration does not appear to influence the long-
term clinical performance of dental implants. The stability of the hard tissue augmented by 
using different biomaterials needs to be further investigated. 
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Introduction 
Today, guided bone regeneration (GBR) is the most widely used and best-
documented method applied to augment bone in localized alveolar defects (Benic & 
Hammerle 2014). There is a large body of short-term clinical evidence documenting that 
survival rates of dental implants placed simultaneously with, or after GBR are similar to 
survival rates of implants placed into native bone (Donos et al. 2008, Merli et al. 2016, Sanz-
Sanchez et al. 2015, Hammerle et al. 2002, Jensen & Terheyden 2009). Most studies with 
internal controls found implant survival rates for a period up to 5 years ranging from 95 to 
100% at both augmented and control sites (Benic et al. 2009, Mayfield et al. 1998, Zitzmann 
et al. 2001, Zumstein et al. 2012). Currently, there is scarce clinical evidence comparing the 
long-term results of implants placed with GBR and those placed into pristine bone. A recent 
clinical study assessed the survival rates of implants either placed with simultaneous with 
GBR or placed into native bone after a mean observation period of 12.5 years (Jung et al. 
2013). It was found that the implant survival rates for the GBR and the control groups 
reached 93% and 95%, respectively.  
With regards to the level of the interproximal marginal bone, the analysis of periapical 
radiographs within previous controlled studies did not reveal any difference between 
implants placed into augmented sites and those placed into native bone (Benic et al. 2009, 
Jung et al. 2013, Mayfield et al. 1998, Zumstein et al. 2012). The criticism of studies 
involving two-dimensional radiographs is the fact that outcome of GBR is assessed by 
measuring the interproximal bone level knowing that bone augmentation is most often 
performed at the buccal aspect of implants. 
Therefore, the primary aim of the present intra-subject controlled study was to test 
whether implants placed simultaneously with GBR differ from implants completely placed 
into pristine bone regarding the 15-year interproximal and buccal marginal bone levels. In 
addition, the change in interproximal marginal bone level from 5 to 15 years, the 15-year 
mucosal level and the periodontal parameters were assessed. 
 
 
 
 5 
Materials and methods 
This study was designed as a 15-year clinical examination with intra-subject 
comparison of implants placed with and without GBR. The study was performed at the Clinic 
of Fixed and Removable Prosthodontics and Dental Material Science, Center of Dental 
Medicine, University of Zurich, Switzerland. The trial was approved by the local ethical 
committee (reference code KEK-ZH 2013-0036; Kantonale Ethik-Kommission, Zurich, 
Switzerland). 
Thirty-two patients were included in the study who had received implants placed with 
simultaneous GBR (test group) and standard implant placement without bone augmentation 
(control group), and who had been examined 5 years after implant placement. The treatment 
procedures and the 5-year assessment were described in detail in a previous publication 
(Benic et al. 2009). Written informed consent was obtained from all the patients prior to the 
examination. 
Treatment procedures 
Depending on the quantity of bone, implants were placed following one of the 
following two procedures:  
• GBR: With simultaneous GBR for the treatment of bone defects including 
dehiscences and infrabony defects. The GBR procedure involved grafting with a 
particulate deproteinized bovine bone mineral (DBBM) (Geistlich Bio-Oss® 
spongiosa granules, Geistlich Pharma AG, Wolhusen, Switzerland), autogenous 
bone harvested from the site of surgery or a mixture of the two. The site was 
covered with a native bilayer collagen membrane (Geistlich Bio-Gide®, Geistlich 
Pharma AG, Wolhusen, Switzerland).  
• Control: Standard implant placement executed in situations with bone volume 
sufficient for complete coverage of the endosseous implant surface.  
All implants exhibited a machined endosseous surface (Brånemark System, Nobel 
Biocare, Kloten, Switzerland). The placement of implants was performed either as type 2, 
type 3, or type 4 procedure (Hammerle et al. 2004). The implants were primarily covered for 
submerged healing and loaded after a minimum healing time of 6 months. There was one 
exception, where healing was obtained with the implant in the transmucosal position and 
prosthetic loading 3 weeks after implant placement. This implant was lost after 4 months 
and, therefore, not included in the clinical and radiographic analyses.  
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Follow-up examination 
The 5-year examination procedure was described in detail in a previous publication 
(Benic et al. 2009). Fifteen years after implant placement, one investigator, who was 
unaware of the specific treatment modality, examined the patients. One test and one control 
implant from each patient were selected for analysis. In each patient, the two study implants 
were located either in the anterior or in the posterior regions of the same jaw. 
 
Outcome variables 
Implant survival 
Implant survival was assessed at the 15-year follow-up examination. The implant 
survival was defined as the implant being in place and stable. The stability of the implant-
supported reconstruction and, if necessary, of the implant were assessed by mechanical 
testing with a hand instrument. 
Interproximal marginal bone level 
At 5 and 15 years, periapical radiographs were taken using the long-cone paralleling 
technique with the central beam aiming at the alveolar crest (Updegrave 1968). The 
radiographs were digitized as jpeg-files and imported into an analysis software (ImageJ, 
National Institute of Health, Bethesda, MD, USA). The interproximal marginal bone level 
(MBLinterprox) was assessed on the mesial and on the distal aspect of each implant by 
measuring the distance from the implant shoulder to the first visible bone-to-implant contact. 
The distance between implant threads was used for the calibration of the distances. Mesial 
and distal MBLinterprox values were averaged to one value per implant. The change in 
MBLinterprox from 5-year to 15-year examination was calculated. A positive change of 
MBLinterprox denoted a loss of marginal bone.  
Buccal bone and mucosa dimensions 
At the 15-year follow-up examination, CBCT imaging was performed with a 3DExam 
CBCT scanner (KaVo Dental, Biberich, Germany). To allow depicting the soft tissues on the 
CBCT, a thin layer of light-curing radio-opaque flowable composite was applied on the peri-
implant mucosa of the study implants and cured (Benic et al. 2012, Jung et al. 2015). The 
scans were made using the following technical parameters: 120 kV, 5 mA, 19 mAs, voxel 
size of 0.125 mm and 360° rotation. Bucco-oral sections perpendicular to the implant central 
axis were used for CBCT analysis (OsiriX imaging software, Geneva, Switzerland).  
The following parameters were assessed at the buccal aspect of each implant:  
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• Buccal marginal bone level (MBLbuccal): apico-coronal distance from the first bone-
to-implant contact to the implant shoulder 
• Bucco-oral bone thickness measured 1, 2 and 3 mm apical to the implant 
shoulder (BT1mm, BT2mm, BT3mm) 
• Marginal mucosa level (MML): apico-coronal distance from the marginal mucosa 
to the implant shoulder  
• Mucosa height (MH): buccal marginal bone level + marginal mucosa level 
• Bucco-oral mucosa thickness measured 1 mm apical to the marginal mucosa 
(MT). 
Clinical parameters 
At 5 and 15 years, the following variables were assessed:  
• Plaque control record (PCR) at 6 sites per implant investigated (O'Leary et al. 
1972),    
• Bleeding on probing score (BOP) at 6 sites per implant investigated (Ainamo & 
Bay 1975), 
• Probing pocket depth (PPD) to the nearest millimeter at 6 sites per implant 
investigated.  
The six values around each implant for PCR, BOP and PPD were averaged to one 
value per implant. The 5- to 15-year changes were calculated. 
Statistical analysis 
The statistical procedure was described in detail in a previous publication (Benic et al. 
2009). The estimation of the implant survival rate was based on Kaplan–Meier analysis and 
a group comparison was made using the log-rank test (R software; R Foundation, Vienna, 
Austria). Only the cases with both test and control implants were used for the following 
analysis. For continuous parameters, the data distributions were represented with boxplots 
and the data were reported by means, standard deviations (SD), medians, 95% confidence 
intervals (95% CI), and ranges (SPSS software; SPSS Inc., Chicago, IL, USA). The paired t-
test was applied to detect differences between the test and the control implants. Results of 
tests with p-values ≤ 0.05 were considered statistically significant (R software; R Foundation, 
Vienna, Austria). To control for multiple testing, the Benjamini and Hochberg False Discovery 
Rate was applied. The power of the comparison between test and control implants had been 
computed for the patient cohort examined at the 5-year examination. It showed > 95% power 
for MBLinterprox.  
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Results 
The results of the assessment at 5 years were published in a previous publication. 
Patients and implants 
At the 15-year examination 23 out of the 32 invited patients were examined. Sixteen 
women and 7 men presented with a median age of 56.8 years (range 18.0 - 74.5 years) at 
implant placement. They had received 23 GBR and 23 control implants. In either group there 
were 9 maxillary and 14 mandibular implants, and 21 posterior and 2 anterior implants. The 
distributions of implant lengths and diameters are presented in Table A1. In 18 patients GBR 
involved grafting with DBBM, alone or in combination with autogenous bone (cohort DBBM). 
In the remaining 5 patients, GBR procedure was executed by grafting with autogenous bone 
only (cohort autogenous bone). The majority of the implants were reconstructed with fixed 
prostheses: 9 with single-crowns and 29 with splinted reconstructions. The other 8 implants 
supported removable prostheses. In 22 of 23 patients, the test and the control implant 
exhibited the same type of reconstruction (Table A1). The follow-up period after implant 
placement ranged from 172 to 209 months (mean and median 15.2 years). 
Implant survival 
One GBR implant was lost between 5 and 15 years, rendering a 15-year implant 
survival rate of 95.6% (95% CI: 87.7%; 100%) for the GBR group. In the control group, two 
implants were lost and the 15-year survival rate amounted to 94.1% (95% CI: 86.5%; 100%). 
One control implant was lost 5 months after implant placement. This implant had been 
loaded only 3 weeks after placement and subsequently became mobile. In another patient, 
one control implant was not osseointegrated at the time of abutment connection, 6 months 
after implant placement. The difference in the 15-year survival rate between the groups was 
not statistically significant (p = 0.56). 
The cases with lost implants were excluded from the statistical analysis of the 
following clinical and radiographic parameters. Therefore, 22 cases with 44 implants were 
included for the analysis. 
Interproximal marginal bone level 
Radiographic evaluation indicated that all implants were successfully osseointegrated 
as seen by close bone-to-implant contact at the implant surface from alveolar crest to the 
apical end. 
At the 5-year examination, the mean MBLinterprox measured 1.33 ± 0.51 for the GBR 
implants and 1.60 ± 0.86 for the control implants (Benic et al. 2009) (Table 1). At 15 years, 
the corresponding values amounted to 1.44 ± 0.84 mm for the GBR group and to 1.69 ± 0.84 
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mm for the control group. The differences between the groups were not statistically 
significant (5 years: p = 0.080; 15 years: p = 0.591). At 15 years, there were 5 out of 22 
(22.7%) implants with a MBLinterprox value > 2 mm in each group. From the 5- to the 15-year 
examination, the change in mean MBLinterprox reached 0.23 ± 0.70 mm for the GBR group and 
0.28 ± 0.63 mm for the control group. The values for the two treatment modalities did not 
significantly differ (p = 696). From 5 to 15 years, there were 3 out of 22 (13.6%) implants with 
> 1 mm of change in mean MBLinterprox in each group. No implant lost > 2 mm of interproximal 
bone level from 5 to 15 years (Fig. 1).  
For the DBBM cohort (n = 17), the 15-year mean MBLinterprox amounted to 1.57 ± 0.84 
mm for the GBR implants and to 1.76 ± 0.86 mm for the control implants without a 
statistically significant difference (p = 0.543) (Table 1). The 15-year mean MBLinterprox reached 
> 2 mm in 5 out of 17 (29.4%) GBR and 5 out of 17 (29.4%) control implants. In the DBBM 
cohort, the change in mean MBLinterprox from 5 to 15 years reached 0.35 ± 0.68 mm for the 
GBR group and 0.28 ± 0.63 mm for the control group. The difference between the GBR and 
the control implants was not statistically significant (p = 0.853). From 5 to 15 years, 3 out of 
17 (17.6%) GBR implants and 1 out of 17 (5.8%) control implants lost > 1 mm of 
interproximal bone level (Fig. 1). 
When considering the patients that received GBR with autogenous bone only (n = 5), 
the 15-year mean MBLinterprox reached 1.01 ± 0.75 mm for the GBR implants and 1.45 ± 0.83 
mm for the control implants (Table 1). In this group of the patients, the 5- to 15-year change 
in mean MBLinterprox amounted to -0.18 ± 0.67 mm for the GBR group and to 0.28 ± 0.71 mm 
for the control group. The differences between the GBR and the control implants did not 
significantly differ (15-year MBLinterprox: p = 0.570; 5- to 15-year change of MBLinterprox: p = 
0.570). 
Buccal marginal bone level and thickness 
Four CBCT were not readable due to beam hardening artifacts caused by prosthetic 
screws made of gold. Therefore, 18 CBCT data sets were analyzed. 
At 15 years, MBLbuccal reached 1.98 ± 0.98 mm for the GBR implants and 2.19 ± 1.29 
mm for the control implants (Table 1). There were 6 out of 18 (33.3%) GBR implants and 7 
out of 18 (38.9%) control implants with a MBLbuccal value > 2 mm (Fig. 2). The values of 
BT1mm, BT2mm and BT3mm at 15 years are presented in Table 1. BT1mm measured 0 mm in 16 
out of 18 (88.9%) GBR implants and in 100% of control implants. The number of implants 
with a BT2mm value of 0 mm was 6 (33.3%) in the GBR group and 7 (38.9%) in the control 
group. There were no significant differences in MBLbuccal and BT between the GBR and the 
control implants (p > 0.5) (Fig. 3a, 4a).  
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When analyzing only the cases that received GBR with DBBM, the 15-year MBLbuccal 
amounted to 2.03 ± 0.99 mm for the GBR implants and to 2.39 ± 1.45 mm for the control 
implants (Table 1, Fig. 3b). The difference between the groups was not statistically 
significant (p = 0.543). There were 4 out of 13 (30.7%) GBR implants and 5 out of 13 
(38.5%) control implants with a MBLbuccal value > 2 mm (Fig. 2). In the cohort DBBM, the 
mean values of BT were higher for the GBR implants than for the control implants (Table 1, 
Fig. 4b). The differences between the groups were, however, not statistically significant (p > 
0.1). BT1mm measured 0 mm in 12 out of 13 (92.3%) GBR implants and in 13 out of 13 
(100%) of control implants. There were 4 (30.8%) GBR implants and 6 (46.2%) control 
implants with a BT2mm value of 0 mm. 
In the cohort autogenous bone, at 15 years, MBLbuccal reached 1.83 ± 1.07 mm for the 
GBR implants and 1.63 ± 0.33 mm for the control implants (Table 1, Fig. 3c). The results of 
BT are presented in Table 1. In this cohort the control implants generally rendered higher 
mean dimensions of the buccal bone, although there were no statistically significant 
differences (p > 0.5) (Fig. 4c).  
Buccal marginal mucosal level and thickness 
At the 15-year follow-up examination, MML measured 1.88 ± 0.83 mm for the GBR 
group and 1.77 ± 0.86 mm for control group (Table 1, Fig. 3a). All the GBR and the control 
implants exhibited sub-mucosal positions of the implant shoulder. In terms of MH, GBR 
implants rendered a mean value of 3.75 ± 1.20 mm and control implants 3.96 ± 1.35 mm. 
The results of MT amounted to 1.08 ± 0.48 for the GBR group and to 1.21 ± 0.46 mm for the 
control group. There were no statistically significant differences in MML, MH and MT 
between the GBR implants and the control implants (p > 0.5). 
The analysis of the DBBM cohort rendered mean values in MML of 1.98 ± 0.85 mm 
for the GBR implants and 1.70 ± 0.86 mm for the control implants (Table 1, Fig. 3b). In this 
cohort MH measured 3.86 ± 1.31 mm for the GBR implants and 4.09 ± 1.52 mm for the 
control implants, while MT reached 1.12 ± 0.52 mm for the GBR group and 1.21 ± 0.49 mm 
for the control group. In the DBBM cohort the differences in MML, MH and MT between the 
GBR and the control implants were not statistically significant (p > 0.1). 
In the autogenous bone cohort, MML reached 1.62 ± 0.79 mm for the GBR implants 
and 1.96 ± 0.93 mm for the control implants (Table 1, Fig. 3c). The mean value in MH for the 
GBR group was 3.45 ± 0.88 mm. The corresponding value for the control implants amounted 
to 3.59 ± 0.75 mm. MT reached 1.01 ± 0.38 mm for the GBR group and 1.24 ± 0.42 mm for 
the control group. For the autogenous bone cohort, the differences in MML, MH and MT 
between the GBR implants and the control implants were not statistically significant (p > 0.5). 
Clinical parameters 
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The 15-year results of PCR, BOP, PPD, and 5- to 15-year changes BOP and PPD 
are presented in Table 2. There were no statistically significant differences in PCR, BOP and 
PPD between the groups (p > 0.5). 
At the 15-year follow-up examination, bleeding on probing occurred in totally 32 out 
of 44 (72.7%) implants. Therefore, according to the specific definition (Sanz et al. 2012), 
peri-implant mucositis was diagnosed at 17 GBR implants and at 15 control implants.  
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Discussion 
The results of the present long-term clinical study indicate that implants placed 
simultaneously to GBR with particulate graft and collagen membrane do not differ from 
implants completely placed into pristine bone with respect to 15-year implant survival and 
interproximal bone levels. Furthermore, there were no differences between the test and the 
control implants regarding the buccal bone and mucosa dimensions and the clinical 
parameters. The majority of the implants at both augmented and control sites exhibited 
stable interproximal bone levels from 5 years to 15 years after implant placement. 
The data for implant survival and interproximal bone levels from the present 
investigation without differences between GBR and control implants confirm the findings of 
previous clinical trials with internal control. In fact, several controlled trials with follow-up 
durations up to 5 years and one clinical study with a mean observation time of 12.5 years did 
not reveal differences in implant survival and interproximal bone level between implants 
placed into augmented sites and those placed into native bone (Benic et al. 2009, Jung et al. 
2013, Mayfield et al. 1998, Zumstein et al. 2012). Moreover, the interproximal bone levels for 
the control and the GBR group in the present study are in agreement with the ones observed 
in long-term studies documenting the outcome of implants placed in native bone under 
standard conditions (Adell et al. 1981, Jemt & Johansson 2006, Ekelund et al. 2003, Jung et 
al. 2013). 
To our knowledge, the present investigation is the first one that compared buccal 
bone and mucosa dimensions at implant sites augmented with GBR to control sites without 
GBR. At the 15-year CBCT examination, there were no significant differences between the 
GBR and the control implants. As far as the dimension of the buccal bone plate is 
concerned, overall, the mean distance between the implant shoulder and the buccal first 
bone-to-implant-contact was approximately 2 mm. Thirteen out 36 (36%) of the implants 
exhibited buccal first-bone-to-implant contact > 2 mm apical to the implant shoulder. 
Several clinical studies measured the dimensions of the buccal bone at implants 
treated with GBR by means of CBCT. Some of these studies assessed the buccal bone at 
implants placed with GBR immediately after tooth extraction and combined with GBR in 
the anterior jaw regions and found pronounced resorption of the buccal bone plate (Benic et 
al. 2012, Kuchler et al. 2016, Miyamoto & Obama 2011). In one study, implants placed 
immediately into extraction sockets were radiographically evaluated after 7 years (Benic et 
al. 2012). At implant placement, infrabony defects and dehiscences were grafted with DBBM 
and covered with collagen membranes (CM) without over-augmenting the remaining buccal 
bone plate. At the 7-year follow-up, in one-third of the sites almost no buccal bone was 
radiographically detected, whereas in the other two-thirds, the buccal bone plate covered the 
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entire rough implant surface. The mucosal margin was located 1 mm more apically within the 
group of implants without radiographically detectable buccal bone. The findings regarding 
the buccal bone plate from this study were confirmed by a 10-year CBCT investigation, in 
which the same treatment protocol was applied (Kuchler et al. 2016). In fact, the patients 
examined in these two studies were originally treated within one multicenter clinical project 
(Lang et al. 2007). After 10 years of function, one-fourth of the sites showed almost no 
buccal bone on the CBCTs (Kuchler et al. 2016). The pronounced resorption of the buccal 
plate observed in the investigations of implants placed into fresh extraction sockets can be 
explained by the post-extractive resorption of the alveolar ridge. 
In contrast, recent CBCT trials of implants placed and treated with GBR at least 6 
weeks after tooth extraction found well maintained levels of the augmented buccal bone 
after 5-9 years (Jung et al. 2015, Buser et al. 2013). In a randomized clinical trial, peri-
implant defects augmented with DBBM and CM were clinically assessed at 6-month re-entry 
and visualized with CBCT after 5 years (Jung et al. 2009, Jung et al. 2015). At 5 years, the 
mean distance between the implant shoulder and the first bone-to-implant-contact was 2.2 
mm. It has, however, to be taken into account that the used soft tissue level implants had a 
machined neck of 1.8 mm. The average thickness of the buccal bone measured at the levels 
1 to 5 mm apical to the most coronal level of the alveolar crest reached 2 to 3 mm. Due to 
the different locations of the regions-of-interest, the results in bone thickness from this study 
cannot be compared with the data found in the present trial. To allow standardized 
measurements, in the present study the bone thickness was assessed at 1 to 3 mm apical to 
the implant shoulder. A clinical CBCT cross-sectional investigation of buccal bone reported 
outcomes after 5-9 years of prosthetic function (Buser et al. 2013). In this study implants 
were placed in the anterior jaw regions 6-8 weeks after tooth extraction and combined with 
simultaneous contour augmentation by means of GBR. The augmentation procedure 
involved grafting with particulate autogenous bone and DBBM, and coverage of the 
augmented sites with CM. The CBCT examination of the facial bone wall revealed a mean 
thickness of 1.6 and 2.2 mm in the regions-of-interest 2 mm and 4 mm apical to the shoulder 
of the soft tissue level implants, respectively. The frequency analysis showed that at the 2-
mm level, representing roughly the beginning of the structured implant surface, 8 of 41 
implants showed no facial bone. At the 4- and 6-mm levels, no facial bone could be detected 
at two implants.  
One of the shortcomings of the present study is represented by the fact that no 
baseline assessments had been performed at implant placement or insertion of the 
reconstruction. Therefore, the buccal bone level at 15 years and not the 15-year change in 
bone level was measured. Another shortcoming of this trial is the high drop out rate at 15 
years resulting in a relatively low sample size. This fact and the variability in the grafting 
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materials used for GBR are considerable limitations, which have to be taken into account 
when interpreting the findings of the present study.  
Another methodological shortcoming of this investigation is that dental implants and 
other highly X-ray absorbing objects cause artifacts within CBCT images (Benic et al. 2013, 
Draenert et al. 2007, Sancho-Puchades et al. 2015, Schulze et al. 2010). It is, therefore, 
controversial whether the peri-implant tissue can accurately be assessed by this technique. 
A recent review of the literature on digital methods for the assessment of outcomes in 
implant dentistry concluded that CBCT has the potential to allow accurate assessment of 
peri-implant bone plates with a thickness > 0.5 mm (Benic et al. 2015). In other words, in the 
present trial the presence of thin buccal bone plates might have been underestimated. Four 
CBCT images had to be excluded from the assessment due to the pronounced presence of 
artifacts that were induced by gold abutment screws. The quality of the remaining CBCT 
images representing implants with titanium abutment screws was rated adequate for the 
assessment of the buccal tissues.  
It is worth noting that in cases in which GBR involved grafting with DBBM, GBR 
implants achieved approximately 0.3-0.4 mm higher mean and median values in buccal bone 
level, bone thickness and mucosal level in comparison to the implants placed into native 
bone without GBR. In contrast, when GBR was performed by grafting with autogenous bone 
without DBBM, implants rendered less favorable results in buccal bone and mucosa 
dimensions than the control implants. The differences between the GBR and the control 
implants were, however, not statistically significant. Due to the low sample size, the 
differences in the buccal bone dimensions found for GBR with DBBM and autogenous bone 
need to be considered with caution. 
The findings of the present trial are clinically relevant. First, they add additional 
comparative evidence on the long-term performance of implants placed into augmented sites 
and those placed into pristine bone without GBR. Second, they provide information on the 
hard and soft tissue dimensions in the regions treated with GBR. Future long-term controlled 
clinical studies with baseline and follow-up measurements are required to confirm the 
findings of the present trial. The stability of the hard tissue augmented by using different 
biomaterials and techniques needs to be further investigated. 
Finally, it is important to emphasize that in the absence of clinical symptoms or 
certain postoperative complications, there is no indication for follow-up imaging of dental 
implants by means of CBCT. Due to the higher radiation burden compared with the two-
dimensional radiography, CBCT imaging cannot be justified where there is no direct benefit 
to the patient, except as part of ethically approved clinical research (Harris et al. 2012, Dula 
et al. 2015).  
 15 
Conclusions 
Within the limitations of the present long-term observation study, it can be concluded 
that: 
• Implants placed simultaneously to GBR using particulate DBBM and/or 
autogenous bone in combination with a native collagen membrane did not 
significantly differ from implants completely placed into pristine bone with respect 
to 15-year implant survival, interproximal bone levels, and dimensions of the 
buccal bone and mucosa. 
• The machined-surface implants placed both into native bone and sites 
augmented by GBR exhibited stable interproximal bone levels over a 15-year 
period. 
• GBR involving grafting with DBBM lead to approximately 0.3-0.4 mm higher mean 
and median values in buccal bone level, bone thickness and mucosal level in 
comparison to control implants placed into native bone without GBR. In contrast, 
GBR performed by grafting with autogenous bone without DBBM rendered less 
favorable results in buccal bone and mucosa dimensions than implant placement 
without GBR. 
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Table legend 
Table 1. Results of the conventional radiographic and CBCT measurements 
Table 2. Results of the clinical measurements 
Table A1. Distributions of implant lengths, implant diameters, and reconstruction 
types presented as absolute values 
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Figure legend 
Figure 1. Frequency distribution of the change in mean interproximal marginal bone 
level from the 5-year to the 15-year examination at control sites, sites in which GBR involved 
grafting with DBBM (GBR DBBM), and sites in which GBR involved grafting with autogenous 
bone only (GBR AB). 
Figure 2. Frequency distribution of the buccal marginal bone level at the 15-year 
examination at control sites, sites in which GBR involved grafting with DBBM (GBR DBBM), 
and sites in which GBR involved grafting with autogenous bone only (GBR AB). 
Figure 3. Box plots representing the buccal marginal bone level (MBLbuccal) and the 
buccal marginal mucosa level (MMLbuccal) relative to the implant shoulder at the 15-year 
examination (a) in the entire study cohort, (b) in patients in which GBR involved grafting with 
DBBM (GBR DBBM) and (c) in patients in which GBR involved grafting with autogenous 
bone only (GBR AB). ° and * in the figures represent the outliers. 
Figure 4. Box plots representing the bucco-oral bone thickness measured 1, 2 and 3 
mm apical to the implant shoulder at the 15-year examination (a) in the entire study cohort, 
(b) in patients in which GBR involved grafting with DBBM (GBR DBBM), and (c) in patients in 
which GBR involved grafting with autogenous bone only (GBR AB). ° and * in the figures 
represent the outliers. 
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        GBR   Control     
Cohort Parameter Time n Mean ± SD Medi
an 
95% CI Range   Mean ± SD Media
n 
95% CI Range   P-value* 
(a) Total                           
  Mean MBLinterprox 5y 32 1.33 ± 0.51 1.34 1.14-1.51 0-2.36   1.60 ± 0.86 1.62 1.29-1.91 0.07-3.64   0.080 
  Mean MBLinterprox 15y 22 1.44 ± 0.84 1.36 1.07-1.82 0-2.87   1.69 ± 0.84 1.48 1.32-2.06 0.24-3.62   0.591 
  Change of mean 
MBLinterprox 
5y-15y 22 0.23 ± 0.70 0.02 -0.07-0.54 -1.11-1.47 0.28 ± 0.63 0.36 -0.01-0.57 -1.37-1.24 0.696 
  MBLbuccal 15y 18 1.98 ± 0.98 1.86 1.49-2.46 0.18-4.70   2.19 ± 1.29 1.61 1.57-2.81 1.14-5.52   0.636 
  BT1mm 15y 18 0.12 ± 0.37 0 -0.06-0.30 0-1.44   0 ± 0 0 0-0 0-0   0.591 
  BT2mm 15y 18 0.82 ± 0.99 0.42 0.32-1.31 0-3.44   0.79 ± 0.75 0.77 0.43-1.16 0-2.25   0.748 
  BT3mm 15y 18 1.41 ± 1.22 1.13 0.81-2.02 0-4.43   1.28 ± 1.07 1.34 0.76-1.79 0-3.55   0.636 
  MML 15y 18 1.88 ± 0.83 2.08 1.45-2.30 0.39-2.91   1.77 ± 0.86 1.76 1.35-2.18 0.78-3.94   0.636 
  MH 15y 18 3.75 ± 1.20 3.50 3.15-4.34 1.53-6.13   3.96 ± 1.35 3.45 3.31-4.61 2.31-7.05   0.741 
  MT 15y 18 1.08 ± 0.48 1.05 0.84-1.33 0.43-2.07   1.21 ± 0.46 1.25 0.99-1.43 0.45-1.93   0.636 
(b) DBBM                           
  Mean MBLinterprox 15y 17 1.57 ± 0.84 1.40 1.13-2.01 0-2.87   1.76 ± 0.86 1.56 1.32-2.20 0.82-3.62   0.543 
  Change of mean 
MBLinterprox 
5y-15y 17 0.35 ± 0.68 0.42 0.01-0.70 -0.64-1.47 0.28 ± 0.63 0.36 -0.05-0.62 -1.37-1.24 0.853 
  MBLbuccal 15y 13 2.03 ± 0.99 1.86 1.44-2.63 0.79-4.70   2.39 ± 1.45 1.70 1.55-3.23 1.14-5.52   0.543 
  BT1mm 15y 13 0.05 ± 0.19 0 -0.06-0.17 0-0.70   0 ± 0 0 0-0 0-0   0.543 
  BT2mm 15y 13 0.91 ± 1.06 0.84 0.27-1.55 0-3.44   0.66 ± 0.73 0.50 0.23-1.08 0-2.25   0.393 
  BT3mm 15y 13 1.60 ± 1.33 1.27 0.79-2.40 0-4.43   1.14 ± 1.17 0.78 0.47-1.82 0-3.55   0.393 
  MML 15y 13 1.98 ± 0.85 2.20 1.44-2.52 0.39-2.91   1.70 ± 0.86 1.56 1.20-2.20 0.78-3.94   0.393 
  MH 15y 13 3.86 ± 1.31 3.57 3.07-4.65 1.53-6.13   4.09 ± 1.52 3.54 3.21-4.96 2.31-7.05   0.798 
  MT 15y 13 1.12 ± 0.52 1.05 0.78-1.45 0.43-2.07   1.21 ± 0.49 1.28 0.92-1.49 0.45-1.93   0.707 
(c) Autogenous bone                           
  Mean MBLinterprox 15y 5 1.01 ± 0.75 1.32 0.08-1.94 0-1.87   1.45 ± 0.83 1.38 0.42-2.48 0.24-2.53   0.570 
  Change of mean 
MBLinterprox 
5y-15y 5 -0.18 ± 0.67 -0.22 -1.01-0.65 -1.11-0.77 0.28 ± 0.71 0.04 -0.60-1.16 -0.54-1.22 0.570 
  MBLbuccal 15y 5 1.83 ± 1.07 1.87 0.50-3.16 0.18-3.08   1.63 ± 0.33 1.52 1.22-2.04 1.39-2.20   0.868 
  BT1mm 15y 5 0.29 ± 0.64 0 -0.51-1.09 0-1.44   0 ± 0 0 0-0 0-0   0.654 
  BT2mm 15y 5 0.58 ± 0.84 0.39 -0.47-1.62 0-2.04   1.17 ± 0.76 1.40 0.23-2.11 0-2.05   0.570 
  BT3mm 15y 5 0.94 ± 0.83 0.75 -0.09-1.97 0-2.25   1.66 ± 0.69 2.08 0.80-2.51 0.54-2.12   0.570 
  MML 15y 5 1.62 ± 0.79 1.36 0.65-2.60 0.62-2.48   1.96 ± 0.93 1.76 0.80-3.12 0.83-3.42   0.654 
  MH 15y 5 3.45 ± 0.88 3.23 2.37-4.54 2.55-4.83   3.59 ± 0.75 3.28 2.66-4.52 3.03-4.87   0.837 
  MT 15y 5 1.01 ± 0.38 1.14 0.54-1.48 0.58-1.49   1.24 ± 0.42 1.11 0.72-1.75 0.71-1.67   0.687 
DBBM, deproteinized bovine bone mineral; MBL, marginal bone level; BTxmm, bone thickness measured xmm apical to the implant shoulder; MML, marginal mucosa level; 
MH, mucosa height; MT, mucosa thickness; y, years; GBR, guided bone regeneration; n, number; SD, standard deviation; 95% CI, 95% confidence interval; *, results of 
paired t-test corrected for multiple testing with Benjamini & Hochberg 
 
Table 1 
  
 
 
 
 
 
 
          GBR   Control     
Coho
rt 
Parameter Time Unit n Mean ± SD Media
n 
95% CI Range   Mean ± SD Media
n 
95% CI Range   P-
value* 
(a) Total                             
  PCR 15y % 22 36.3 ± 30.7 33.0 22.7-49.9 0-100   30.4 ± 36.2 17.0 14.3-46.4 0-100   0.591 
  BOP 15y % 22 46.2 ± 27.7 50.0 33.9-58.5 0-100   38.3 ± 28.8 30.0 25.4-51.1 0-100   0.591 
  Mean PPD 15y mm 22 3.12 ± 0.71 3.00 2.80-3.43 2.00-5.17   3.05 ± 0.67 3.00 2.75-3.35 2.00-4.67   0.696 
(b) DBBM                             
  PCR 15y % 18 36.1 ± 30.2 33.0 20.6-51.7 0-100   32.4 ± 35.0 17.0 14.4-50.4 0-100   0.689 
  BOP 15y % 18 46.1 ± 28.1 50.0 31.6-60.5 0-100   35.8 ± 25.8 30.0 22.5-49.0 0-83.0   0.393 
  Mean PPD 15y mm 18 3.04 ± 0.73 3.00 2.66-3.41 2.00-5.17   3.06 ± 0.74 3.00 2.68-3.44 2.00-4.67   0.853 
(c) Autogenous bone                             
  PCR 15y % 5 36.8 ± 36.0 17.0 -7.9-81.5 0-83.0   23.4 ± 43.4 0 -30.6-77.4 0-100   0.654 
  BOP 15y % 5 46.8 ± 29.6 50.0 10.0-83.6 17.0-83.0   46.8 ± 39.8 50.0 -2.6-96.2 0-100   1.000 
  Mean PPD 15y mm 5 3.39 ± 0.65 3.17 2.58-4.20 2.83-4.30   2.99 ± 0.42 3.00 2.48-3.51 2.50-3.50   0.654 
DBBM, deproteinized bovine bone mineral; PCR, plaque control record; BOP, bleeding on probing; PPD, probing pocket depth; y, years; GBR, guided bone 
regeneration; n, number; SD, standard deviation; 95% CI, 95% confidence interval; *, results of paired t-test corrected for multiple testing with Benjamini & 
Hochberg 
 
Table 2 
 
  
 
 
 
 
 
 
    GBR (n = 23) Control (n= 23) 
Implant length (mm)       
  7 1 1 
  8.5 4 5 
  10 4 7 
  11.5 7 5 
  13 7 5 
Implant diameter (mm)       
  3.3 1 1 
  3.75-4.0 18 17 
  5.0 4 5 
Reconstruction type       
  Fixed single 4 5 
  Fixed splinted 15 14 
  Removable single 0 0 
  Removable 
splinted 
4 4 
GBR, guided bone regeneration; n, number 
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